Click for best price
Antisense Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Antisense Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Therapy. This report contains market size and forecasts of Antisense Therapy in global, including the following market information:
Global Antisense Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Antisense Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
RNA Antisense Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antisense Therapy include Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Inc., Arbutus Biopharma (Tekmira), Isarna Therapeutics, Arrowhead, Dicerna Pharmaceuticals, Quark Pharmaceuticals, Benitec Biopharma and Sylentis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antisense Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antisense Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Antisense Therapy Market Segment Percentages, by Type, 2022 (%)
RNA Antisense Therapy
DNA Antisense Therapy
Global Antisense Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Antisense Therapy Market Segment Percentages, by Application, 2022 (%)
Cancer
Cardiovascular
HBV
Other
Global Antisense Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Antisense Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antisense Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antisense Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals
Ionis Pharmaceuticals, Inc.
Arbutus Biopharma (Tekmira)
Isarna Therapeutics
Arrowhead
Dicerna Pharmaceuticals
Quark Pharmaceuticals
Benitec Biopharma
Sylentis
Gradalis
Sarepta Therapeutics
Biogen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antisense Therapy, market overview.
Chapter 2: Global Antisense Therapy market size in revenue.
Chapter 3: Detailed analysis of Antisense Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antisense Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antisense Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antisense Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antisense Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antisense Therapy Overall Market Size
2.1 Global Antisense Therapy Market Size: 2022 VS 2030
2.2 Global Antisense Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antisense Therapy Players in Global Market
3.2 Top Global Antisense Therapy Companies Ranked by Revenue
3.3 Global Antisense Therapy Revenue by Companies
3.4 Top 3 and Top 5 Antisense Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antisense Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antisense Therapy Players in Global Market
3.6.1 List of Global Tier 1 Antisense Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Antisense Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antisense Therapy Market Size Markets, 2022 & 2030
4.1.2 RNA Antisense Therapy
4.1.3 DNA Antisense Therapy
4.2 By Type - Global Antisense Therapy Revenue & Forecasts
4.2.1 By Type - Global Antisense Therapy Revenue, 2018-2023
4.2.2 By Type - Global Antisense Therapy Revenue, 2024-2030
4.2.3 By Type - Global Antisense Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antisense Therapy Market Size, 2022 & 2030
5.1.2 Cancer
5.1.3 Cardiovascular
5.1.4 HBV
5.1.5 Other
5.2 By Application - Global Antisense Therapy Revenue & Forecasts
5.2.1 By Application - Global Antisense Therapy Revenue, 2018-2023
5.2.2 By Application - Global Antisense Therapy Revenue, 2024-2030
5.2.3 By Application - Global Antisense Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Antisense Therapy Market Size, 2022 & 2030
6.2 By Region - Global Antisense Therapy Revenue & Forecasts
6.2.1 By Region - Global Antisense Therapy Revenue, 2018-2023
6.2.2 By Region - Global Antisense Therapy Revenue, 2024-2030
6.2.3 By Region - Global Antisense Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Antisense Therapy Revenue, 2018-2030
6.3.2 US Antisense Therapy Market Size, 2018-2030
6.3.3 Canada Antisense Therapy Market Size, 2018-2030
6.3.4 Mexico Antisense Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Antisense Therapy Revenue, 2018-2030
6.4.2 Germany Antisense Therapy Market Size, 2018-2030
6.4.3 France Antisense Therapy Market Size, 2018-2030
6.4.4 U.K. Antisense Therapy Market Size, 2018-2030
6.4.5 Italy Antisense Therapy Market Size, 2018-2030
6.4.6 Russia Antisense Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Antisense Therapy Market Size, 2018-2030
6.4.8 Benelux Antisense Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Antisense Therapy Revenue, 2018-2030
6.5.2 China Antisense Therapy Market Size, 2018-2030
6.5.3 Japan Antisense Therapy Market Size, 2018-2030
6.5.4 South Korea Antisense Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Antisense Therapy Market Size, 2018-2030
6.5.6 India Antisense Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Antisense Therapy Revenue, 2018-2030
6.6.2 Brazil Antisense Therapy Market Size, 2018-2030
6.6.3 Argentina Antisense Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antisense Therapy Revenue, 2018-2030
6.7.2 Turkey Antisense Therapy Market Size, 2018-2030
6.7.3 Israel Antisense Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Antisense Therapy Market Size, 2018-2030
6.7.5 UAE Antisense Therapy Market Size, 2018-2030
7 Antisense Therapy Companies Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Company Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals Antisense Therapy Major Product Offerings
7.1.4 Alnylam Pharmaceuticals Antisense Therapy Revenue in Global Market (2018-2023)
7.1.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.2 Ionis Pharmaceuticals, Inc.
7.2.1 Ionis Pharmaceuticals, Inc. Company Summary
7.2.2 Ionis Pharmaceuticals, Inc. Business Overview
7.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Major Product Offerings
7.2.4 Ionis Pharmaceuticals, Inc. Antisense Therapy Revenue in Global Market (2018-2023)
7.2.5 Ionis Pharmaceuticals, Inc. Key News & Latest Developments
7.3 Arbutus Biopharma (Tekmira)
7.3.1 Arbutus Biopharma (Tekmira) Company Summary
7.3.2 Arbutus Biopharma (Tekmira) Business Overview
7.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Major Product Offerings
7.3.4 Arbutus Biopharma (Tekmira) Antisense Therapy Revenue in Global Market (2018-2023)
7.3.5 Arbutus Biopharma (Tekmira) Key News & Latest Developments
7.4 Isarna Therapeutics
7.4.1 Isarna Therapeutics Company Summary
7.4.2 Isarna Therapeutics Business Overview
7.4.3 Isarna Therapeutics Antisense Therapy Major Product Offerings
7.4.4 Isarna Therapeutics Antisense Therapy Revenue in Global Market (2018-2023)
7.4.5 Isarna Therapeutics Key News & Latest Developments
7.5 Arrowhead
7.5.1 Arrowhead Company Summary
7.5.2 Arrowhead Business Overview
7.5.3 Arrowhead Antisense Therapy Major Product Offerings
7.5.4 Arrowhead Antisense Therapy Revenue in Global Market (2018-2023)
7.5.5 Arrowhead Key News & Latest Developments
7.6 Dicerna Pharmaceuticals
7.6.1 Dicerna Pharmaceuticals Company Summary
7.6.2 Dicerna Pharmaceuticals Business Overview
7.6.3 Dicerna Pharmaceuticals Antisense Therapy Major Product Offerings
7.6.4 Dicerna Pharmaceuticals Antisense Therapy Revenue in Global Market (2018-2023)
7.6.5 Dicerna Pharmaceuticals Key News & Latest Developments
7.7 Quark Pharmaceuticals
7.7.1 Quark Pharmaceuticals Company Summary
7.7.2 Quark Pharmaceuticals Business Overview
7.7.3 Quark Pharmaceuticals Antisense Therapy Major Product Offerings
7.7.4 Quark Pharmaceuticals Antisense Therapy Revenue in Global Market (2018-2023)
7.7.5 Quark Pharmaceuticals Key News & Latest Developments
7.8 Benitec Biopharma
7.8.1 Benitec Biopharma Company Summary
7.8.2 Benitec Biopharma Business Overview
7.8.3 Benitec Biopharma Antisense Therapy Major Product Offerings
7.8.4 Benitec Biopharma Antisense Therapy Revenue in Global Market (2018-2023)
7.8.5 Benitec Biopharma Key News & Latest Developments
7.9 Sylentis
7.9.1 Sylentis Company Summary
7.9.2 Sylentis Business Overview
7.9.3 Sylentis Antisense Therapy Major Product Offerings
7.9.4 Sylentis Antisense Therapy Revenue in Global Market (2018-2023)
7.9.5 Sylentis Key News & Latest Developments
7.10 Gradalis
7.10.1 Gradalis Company Summary
7.10.2 Gradalis Business Overview
7.10.3 Gradalis Antisense Therapy Major Product Offerings
7.10.4 Gradalis Antisense Therapy Revenue in Global Market (2018-2023)
7.10.5 Gradalis Key News & Latest Developments
7.11 Sarepta Therapeutics
7.11.1 Sarepta Therapeutics Company Summary
7.11.2 Sarepta Therapeutics Business Overview
7.11.3 Sarepta Therapeutics Antisense Therapy Major Product Offerings
7.11.4 Sarepta Therapeutics Antisense Therapy Revenue in Global Market (2018-2023)
7.11.5 Sarepta Therapeutics Key News & Latest Developments
7.12 Biogen
7.12.1 Biogen Company Summary
7.12.2 Biogen Business Overview
7.12.3 Biogen Antisense Therapy Major Product Offerings
7.12.4 Biogen Antisense Therapy Revenue in Global Market (2018-2023)
7.12.5 Biogen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Antisense Therapy Market Opportunities & Trends in Global Market
Table 2. Antisense Therapy Market Drivers in Global Market
Table 3. Antisense Therapy Market Restraints in Global Market
Table 4. Key Players of Antisense Therapy in Global Market
Table 5. Top Antisense Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antisense Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antisense Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antisense Therapy Product Type
Table 9. List of Global Tier 1 Antisense Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antisense Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Antisense Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Antisense Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antisense Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Antisense Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Antisense Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antisense Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Antisense Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Antisense Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antisense Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Antisense Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antisense Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Antisense Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antisense Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Antisense Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antisense Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Antisense Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antisense Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Antisense Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antisense Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Alnylam Pharmaceuticals Company Summary
Table 31. Alnylam Pharmaceuticals Antisense Therapy Product Offerings
Table 32. Alnylam Pharmaceuticals Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Alnylam Pharmaceuticals Key News & Latest Developments
Table 34. Ionis Pharmaceuticals, Inc. Company Summary
Table 35. Ionis Pharmaceuticals, Inc. Antisense Therapy Product Offerings
Table 36. Ionis Pharmaceuticals, Inc. Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Ionis Pharmaceuticals, Inc. Key News & Latest Developments
Table 38. Arbutus Biopharma (Tekmira) Company Summary
Table 39. Arbutus Biopharma (Tekmira) Antisense Therapy Product Offerings
Table 40. Arbutus Biopharma (Tekmira) Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Arbutus Biopharma (Tekmira) Key News & Latest Developments
Table 42. Isarna Therapeutics Company Summary
Table 43. Isarna Therapeutics Antisense Therapy Product Offerings
Table 44. Isarna Therapeutics Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Isarna Therapeutics Key News & Latest Developments
Table 46. Arrowhead Company Summary
Table 47. Arrowhead Antisense Therapy Product Offerings
Table 48. Arrowhead Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Arrowhead Key News & Latest Developments
Table 50. Dicerna Pharmaceuticals Company Summary
Table 51. Dicerna Pharmaceuticals Antisense Therapy Product Offerings
Table 52. Dicerna Pharmaceuticals Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Dicerna Pharmaceuticals Key News & Latest Developments
Table 54. Quark Pharmaceuticals Company Summary
Table 55. Quark Pharmaceuticals Antisense Therapy Product Offerings
Table 56. Quark Pharmaceuticals Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Quark Pharmaceuticals Key News & Latest Developments
Table 58. Benitec Biopharma Company Summary
Table 59. Benitec Biopharma Antisense Therapy Product Offerings
Table 60. Benitec Biopharma Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Benitec Biopharma Key News & Latest Developments
Table 62. Sylentis Company Summary
Table 63. Sylentis Antisense Therapy Product Offerings
Table 64. Sylentis Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Sylentis Key News & Latest Developments
Table 66. Gradalis Company Summary
Table 67. Gradalis Antisense Therapy Product Offerings
Table 68. Gradalis Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Gradalis Key News & Latest Developments
Table 70. Sarepta Therapeutics Company Summary
Table 71. Sarepta Therapeutics Antisense Therapy Product Offerings
Table 72. Sarepta Therapeutics Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Sarepta Therapeutics Key News & Latest Developments
Table 74. Biogen Company Summary
Table 75. Biogen Antisense Therapy Product Offerings
Table 76. Biogen Antisense Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Biogen Key News & Latest Developments
List of Figures
Figure 1. Antisense Therapy Segment by Type in 2022
Figure 2. Antisense Therapy Segment by Application in 2022
Figure 3. Global Antisense Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antisense Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Antisense Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antisense Therapy Revenue in 2022
Figure 8. By Type - Global Antisense Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Antisense Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Antisense Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Antisense Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Antisense Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Antisense Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Antisense Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Antisense Therapy Revenue Market Share, 2018-2030
Figure 16. US Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Antisense Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Antisense Therapy Revenue Market Share, 2018-2030
Figure 28. China Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Antisense Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Antisense Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Antisense Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Alnylam Pharmaceuticals Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Ionis Pharmaceuticals, Inc. Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Arbutus Biopharma (Tekmira) Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Isarna Therapeutics Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Arrowhead Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Dicerna Pharmaceuticals Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Quark Pharmaceuticals Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Benitec Biopharma Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sylentis Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Gradalis Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Sarepta Therapeutics Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Biogen Antisense Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
